Imvax Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers. | |||
Founding Date | Founding Date 1997 | Founding Date 1996 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations London, GB HQ Oxford, GB | Locations ID HQ | Locations Philadelphia, US HQ |
Employees | Employees 6 | Employees 14,616 | Employees 2723% decrease |
Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers.
View company